|
|
|
Volumn 69, Issue 8, 2011, Pages 1505-1514
|
|
[Exploring an optimal approach to the use of oral hypoglycemic agents based on CGM results: implications for combination therapy with oral hypoglycemic agents].
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2,4 THIAZOLIDINEDIONE DERIVATIVE;
ANTIDIABETIC AGENT;
BIGUANIDE DERIVATIVE;
DIPEPTIDYL PEPTIDASE IV INHIBITOR;
GLYCOSYLATED HEMOGLOBIN;
HEMOGLOBIN A1C PROTEIN, HUMAN;
SULFONYLUREA DERIVATIVE;
ARTICLE;
DRUG COMBINATION;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
NON INSULIN DEPENDENT DIABETES MELLITUS;
ORAL DRUG ADMINISTRATION;
ADMINISTRATION, ORAL;
BIGUANIDES;
DIABETES MELLITUS, TYPE 2;
DIPEPTIDYL-PEPTIDASE IV INHIBITORS;
DRUG THERAPY, COMBINATION;
FEMALE;
HEMOGLOBIN A, GLYCOSYLATED;
HUMANS;
HYPOGLYCEMIC AGENTS;
MALE;
MIDDLE AGED;
SULFONYLUREA COMPOUNDS;
THIAZOLIDINEDIONES;
|
|
EID: 80053436612
PISSN: 00471852
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
